Liver histology during Mipomersen therapy for severe hypercholesterolemia (2014)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.jacl.2014.08.002
- Subjects: HIPERCOLESTEROLEMIA (TERAPIA); FÍGADO (ANATOMIA E HISTOLOGIA); FÁRMACOS (SISTEMA DIGESTÓRIO)
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Clinical Lipidology
- Volume/Número/Paginação/Ano: v. 8, n. 6, p. 606-611, 2014
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
HASHEMI, Nikroo et al. Liver histology during Mipomersen therapy for severe hypercholesterolemia. Journal of Clinical Lipidology, v. 8, n. 6, p. 606-611, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.jacl.2014.08.002. Acesso em: 12 fev. 2026. -
APA
Hashemi, N., Odze, R. D., McGowan, M. P., & Santos, R. D. (2014). Liver histology during Mipomersen therapy for severe hypercholesterolemia. Journal of Clinical Lipidology, 8( 6), 606-611. doi:10.1016/j.jacl.2014.08.002 -
NLM
Hashemi N, Odze RD, McGowan MP, Santos RD. Liver histology during Mipomersen therapy for severe hypercholesterolemia [Internet]. Journal of Clinical Lipidology. 2014 ; 8( 6): 606-611.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.jacl.2014.08.002 -
Vancouver
Hashemi N, Odze RD, McGowan MP, Santos RD. Liver histology during Mipomersen therapy for severe hypercholesterolemia [Internet]. Journal of Clinical Lipidology. 2014 ; 8( 6): 606-611.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.jacl.2014.08.002 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
Informações sobre o DOI: 10.1016/j.jacl.2014.08.002 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
